Insights into the comorbidity between type 2 diabetes and osteoarthritis.
暂无分享,去创建一个
G. Davey Smith | A. Morris | A. Hartley | G. Katsoula | E. Zeggini | A. L. de Santana Villasboas Arruda | A. Hartley | G. Katsoula | G. E. Davey Smith | A. Morris | E. Zeggini | A. L. de Santana Villasboas Arruda
[1] E. McDonagh,et al. Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs , 2022, Nature Reviews Drug Discovery.
[2] E. Zeggini,et al. A molecular map of long non-coding RNA expression, isoform switching and alternative splicing in osteoarthritis , 2022, Human molecular genetics.
[3] G. Davey Smith,et al. Harnessing tissue-specific genetic variation to dissect putative causal pathways between body mass index and cardiometabolic phenotypes. , 2022, American journal of human genetics.
[4] Tom R. Gaunt,et al. Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations , 2021, Cell.
[5] J. V. van Meurs,et al. Using multivariable Mendelian randomization to estimate the causal effect of bone mineral density on osteoarthritis risk, independently of body mass index , 2021, medRxiv.
[6] E. Zeggini,et al. A molecular quantitative trait locus map for osteoarthritis , 2021, Nature Communications.
[7] A. Espelt,et al. Multimorbidity and its associated factors among adults aged 50 and over: A cross-sectional study in 17 European countries , 2021, PloS one.
[8] E. Bonifacio,et al. Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories toward type 2 diabetes , 2020, bioRxiv.
[9] Stephen Burgess,et al. A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits , 2019, Nature Communications.
[10] Yoshiya Tanaka,et al. Safety and efficacy of fostamatinib in rheumatoid arthritis patients with an inadequate response to methotrexate in phase II OSKIRA-ASIA-1 and OSKIRA-ASIA-1X study. , 2020, Rheumatology.
[11] A. Martín-Montalvo,et al. Thyroid hormones in diabetes, cancer, and aging , 2020, Aging cell.
[12] J. Frias. Tirzepatide: a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) dual agonist in development for the treatment of type 2 diabetes , 2020, Expert review of endocrinology & metabolism.
[13] Eun Sug Park,et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.
[14] Stephen C. J. Parker,et al. Genetic variant effects on gene expression in human pancreatic islets and their implications for T2D , 2020, Nature Communications.
[15] Y. Leung,et al. Diabetes mellitus is not a risk factor for osteoarthritis , 2020, RMD Open.
[16] J. Aronson,et al. Naltrexone-bupropion (Mysimba®) in management of obesity: a systematic review and meta-analysis of unpublished clinical study reports. , 2020, British journal of clinical pharmacology.
[17] M. Abney,et al. Genome-Wide Associations Reveal Human-Mouse Genetic Convergence and Modifiers of Myogenesis, CPNE1 and STC2. , 2019, American journal of human genetics.
[18] C. Cooper,et al. Type 2 diabetes mellitus and osteoarthritis. , 2019, Seminars in arthritis and rheumatism.
[19] M. Prince,et al. Prevalence of multimorbidity in community settings: A systematic review and meta-analysis of observational studies , 2019, Journal of comorbidity.
[20] P. Raina,et al. Multimorbidity and comorbidity revisited: refining the concepts for international health research. , 2019, Journal of clinical epidemiology.
[21] C. Helmick,et al. Prevalence of Arthritis Among Adults with Prediabetes and Arthritis-Specific Barriers to Important Interventions for Prediabetes — United States, 2009–2016 , 2018, MMWR. Morbidity and mortality weekly report.
[22] Anthony J. Payne,et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps , 2018, Nature Genetics.
[23] P. Donnelly,et al. The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.
[24] Samuel E. Jones,et al. Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry , 2018, bioRxiv.
[25] P. Visscher,et al. Meta-analysis of genome-wide association studies for height and body mass index in ∼700,000 individuals of European ancestry , 2018, bioRxiv.
[26] Valeriia Haberland,et al. The MR-Base platform supports systematic causal inference across the human phenome , 2018, eLife.
[27] Kari Stefansson,et al. Genome-wide analyses using UK Biobank data provide insights into the genetic architecture of osteoarthritis , 2018, Nature Genetics.
[28] Giovanni Malerba,et al. Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes , 2017, Nature Genetics.
[29] F. Cantatore,et al. Osteoblast role in osteoarthritis pathogenesis , 2017, Journal of cellular physiology.
[30] John P. Overington,et al. The druggable genome and support for target identification and validation in drug development , 2016, Science Translational Medicine.
[31] T. Jin. Current Understanding on Role of the Wnt Signaling Pathway Effector TCF7L2 in Glucose Homeostasis. , 2016, Endocrine reviews.
[32] B. Alman,et al. Hedgehog inhibits β-catenin activity in synovial joint development and osteoarthritis. , 2016, The Journal of clinical investigation.
[33] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[34] Emma Ahlqvist,et al. Identification of novel genes for glucose metabolism based upon expression pattern in human islets and effect on insulin secretion and glycemia. , 2015, Human molecular genetics.
[35] M. Daly,et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.
[36] A. Gelber,et al. Osteoarthritis , 2020, Annals of Internal Medicine.
[37] N. Cox,et al. Obesity-associated variants within FTO form long-range functional connections with IRX3 , 2014, Nature.
[38] Tom S. Price,et al. Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis. , 2014, American journal of human genetics.
[39] C. Wallace,et al. Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics , 2013, PLoS genetics.
[40] B. Olsen,et al. Osteoblast–adipocyte lineage plasticity in tissue development, maintenance and pathology , 2014, Cellular and Molecular Life Sciences.
[41] T. Kanamoto,et al. OBIF, an osteoblast induction factor, plays an essential role in bone formation in association with osteoblastogenesis , 2012, Development, growth & differentiation.
[42] G. Davey Smith,et al. Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. , 2012, International journal of epidemiology.
[43] Ralf Herwig,et al. ConsensusPathDB: toward a more complete picture of cell biology , 2010, Nucleic Acids Res..
[44] W. B. van den Berg,et al. To seek shelter from the WNT in osteoarthritis? WNT-signaling as a target for osteoarthritis therapy. , 2010, Current drug targets.
[45] L. Ray,et al. Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics. , 2010, CNS & neurological disorders drug targets.
[46] Philippe Froguel,et al. Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations. , 2009, American journal of human genetics.
[47] Jonathan A C Sterne,et al. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. , 2007, American journal of epidemiology.
[48] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[49] D. Payan,et al. R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation , 2006, Journal of Pharmacology and Experimental Therapeutics.
[50] S. Norby. [Mendelian randomization]. , 2005, Ugeskrift for laeger.
[51] Gideon A. Rodan,et al. Control of osteoblast function and regulation of bone mass , 2003, Nature.